↓ Skip to main content

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma

Overview of attention for article published in Genome Medicine, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news
1 news outlet
twitter
10 X users

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
Published in
Genome Medicine, March 2019
DOI 10.1186/s13073-019-0631-0
Pubmed ID
Authors

Marc Ladanyi, Francisco Sanchez Vega, Marjorie Zauderer

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 21%
Student > Bachelor 6 15%
Researcher 5 13%
Other 4 10%
Student > Postgraduate 2 5%
Other 5 13%
Unknown 9 23%
Readers by discipline Count As %
Medicine and Dentistry 10 26%
Biochemistry, Genetics and Molecular Biology 9 23%
Agricultural and Biological Sciences 2 5%
Immunology and Microbiology 2 5%
Social Sciences 1 3%
Other 3 8%
Unknown 12 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2019.
All research outputs
#1,948,597
of 23,136,540 outputs
Outputs from Genome Medicine
#432
of 1,451 outputs
Outputs of similar age
#46,275
of 351,304 outputs
Outputs of similar age from Genome Medicine
#7
of 21 outputs
Altmetric has tracked 23,136,540 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,451 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,304 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.